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Background: The objective of this study was to examine the cross-cultural differences of the PANSS across six
geo-cultural regions. The specific aims are (1) to examine measurement properties of the PANSS; and (2) to
examine how each of the 30 items function across geo-cultural regions.
Methods: Data was obtained for 1,169 raters from 6 different regions: Eastern Asia (n = 202), India (n = 185),
Northern Europe (n = 126), Russia & Ukraine (n = 197), Southern Europe (n = 162), United States (n = 297). A
principle components analysis assessed unidimensionality of the subscales. Rasch rating scale analysis examined
cross-cultural differences among each item of the PANSS.
Results: Lower item values reflects items in which raters often showed less variation in the scores; higher item
values reflects items with more variation in the scores. Positive Subscale: Most regions found item P5 (Excitement)
to be the most difficult item to score. Items varied in severity from −0.93 [item P6. Suspiciousness/persecution
(USA) to 0.69 item P4. Excitement (Eastern Asia)]. Item P3 (Hallucinatory Behavior) was the easiest item to score for
all geographical regions. Negative Subscale: The most difficult item to score for all regions is N7 (Stereotyped
Thinking) with India showing the most difficulty Δ = 0.69, and Northern Europe and the United States showing the
least difficulty Δ = 0.21, each. The second most difficult item for raters to score was N1 (Blunted Affect) for most
countries including Southern Europe (Δ = 0.30), Eastern Asia (Δ = 0.28), Russia & Ukraine (Δ = 0.22) and India (Δ = 0.10).
General Psychopathology: The most difficult item for raters to score for all regions is G4 (Tension) with difficulty levels
ranging from Δ = 1.38 (India) to Δ = 0.72.
Conclusions: There were significant differences in response to a number of items on the PANSS, possibly caused by a
lack of equivalence between the original and translated versions, cultural differences among interpretation of items or
scoring parameters. Knowing which items are problematic for various cultures can help guide PANSS training and
make training specialized for specific geographical regions.Background
Psychopathology encompasses different types of condi-
tions, causes and consequences, including cultural, phys-
ical, psychological, interpersonal and temporal dimensions.
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reproduction in any medium, provided the ora clinician (or, rater) of the experience of the individual,
and is generally based on the rater’s subjective perceptions
[1]. Structured or semi-structured interview guides have
aided in increasing rater consistency by standardizing the
framework in which diagnostic severity is measured. In
clinical trials, good inter-rater reliability is central to redu-
cing error variance and achieving adequate statistical
power for a study – or at least preserving the estimated
sample size outlined in the original protocol. Inter-rater re-
liability typically is established in these studies through
rater training programs to ensure competent use of se-
lected measures.d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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(American Educational Research Association, AERA [2])
indicate that test equivalence include assessing construct,
functional, translational, cultural and metric categories. Al-
though, many assessments used in psychopathology have
examined construct, functional, translational and metric
categories of rating scales, except for a handful of studies
[3,4], the significance of clinical rater differences across
cultures in schizophrenia rating scales has rarely been in-
vestigated. There is ample research demonstrating the pen-
chant for clinical misdiagnosis and broad interpretation of
symptoms between races, ethnicities, and cultures, usually
Caucasian American or European vis-à-vis an “other.” For
example, van Os and Kapur [5], and Myers [6] point to a
variation in cross-cultural psychopathology ratings. The
presence of these findings suggests that the results of psy-
chiatric rating scales may not adequately assess cultural
disparities not only in symptom expression but also in rater
judgment of those symptoms and their severity. Several
primary methods have been championed in the past dec-
ade as means to aid in the implementation of evaluation
methods in the face of cultural diversity [7-9]. These ap-
proaches, still in their infancy, have yielded positive results
in the areas of diagnosis, treatment, and care of patients,
but they still require reevaluation and additional adjust-
ment [10-12]. As clinical trials become increasingly global,
it is imperative to understand the limitations of current
tools and to adapt, or to augment methods where, and
when necessary.
One of the most widely used measures of psychopath-
ology of schizophrenia in clinical research is the Positive
and Negative Syndrome Scale (PANSS) [13-15]. Since its
development, the PANSS has become a benchmark when
screening and assessing change, in both clinical and re-
search patients. The strengths of the PANSS include its
structured interview, robust factor dimensions, reliability
[13,16,17], availability of detailed anchor points, and valid-
ity. However, a number of psychometric issues have been
raised concerning assessment of schizophrenia across lan-
guages and culture [18]. Given the widespread use of the
PANSS in schizophrenia and related disorders as well as
the increasing globalization of clinical trials, understand-
ing of the psychometric properties of the scale across cul-
tures is of considerable interest.
Most international prevalence data for mental health
is difficult to compare because of diverse diagnostic cri-
teria, differences in perceptions of symptoms, clinical
terminology, and the rating scales used. For example, in
cross-cultural studies with social variables, such as be-
havior, it is often assumed that differences in scores can
be compared at face value. In non-psychotic psychiatric
illnesses, cultural background has been shown to have
substantial influence on the interpretation of behavior as
either normal or pathological [19]. This suggests thatstudies using behavioral rating scales for any disorder
should not be undertaken in the absence of prior know-
ledge about cross-cultural differences when interpreting
the behaviors of interest.
There are a number of methodological issues when eval-
uating cross-cultural differences using results obtained
from rating scales [20-23]. Rasch models have been used
to examine and account for, cross-cultural bias [24].
Riordan and Vandenberg [25] (p. 644) discussed two focal
issues in measurement equivalence across cultures, (1)
whether rating scales elicit the same frame of reference in
culturally diverse groups, and (2) whether raters calibrate
the anchor points (or scoring options) in the same man-
ner. Having non-equivalence in rating scales among cul-
tures can be a serious threat to the validity of quantitative
cross-cultural comparison studies as it is difficult to tell
whether the differences observed are reflecting reality. To
guide decision-making on the most appropriate differ-
ences within a sample, studies advocate more comprehen-
sive analyses using psychometric methods such as Rasch
analysis [24-26]. To date, few studies have used Rasch ana-
lysis to assess the psychometric properties of the PANSS
[27-30]. Rasch analysis can provide evidence of anomalies
with respect to two or more cultural groups in which an
item can show differential item functioning (DIF). DIF can
be used to establish whether a particular group show dif-
ferent scoring patterns within a rating scale [31-33]. DIF
has been used to examine differences in rating scale scores
with respect to translation, country, gender, ethnicity, age,
and education level [34,35].
The goal of this study was to examine the cross-
cultural validity of the PANSS across six geo-cultural
groups (Eastern Asia, India, Northern Europe, Russia
& Ukraine, Southern Europe, and the United States of
America) for data obtained from United States training
videos (translated and subtitled for other languages).
The study examines (1) measurement properties of the
PANSS, namely dimensionality and score structure
across cultures, (2) the validity of the PANSS across
geo-cultural groups when assessing a patient from the
United States, and (3) ways to enhance rater training
based on cross-cultural differences in the PANSS.
Methods
Measures
The PANSS [13] is a 30-item scale used to evaluate the
presence, absence and severity of Positive, Negative and
General Psychopathology symptoms of schizophrenia. Each
subscale contains individual items. The 30 items are ar-
ranged as seven positive symptom subscale items (P1 - P7),
seven negative symptom subscale items (N1 - N7), and 16
general psychopathology symptom items (G1 - G16). All 30
items are rated on a 7-point scale (1 = absent; 7 = extreme).
The PANSS was developed with a comprehensive anchor
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ability of ratings. The potential range of scores on the Posi-
tive and Negative scales are 7 – 49, a score of 7 indicating
no symptoms. The potential range of scores on the General
Psychopathology Scale is 16 – 112.
The PANSS was scored by a clinician trained in psychi-
atric interview techniques, with experience working with
the schizophrenia population (e.g., psychiatrists, mental
healthcare professionals). A semi structured interview for
the PANSS, the SCI-PANSS [36], was used as a guide dur-
ing the interview.
Currently there are over 40 official language versions of
the PANSS. This translation work has been carried out
according to international guidelines, in co-operation
between specific sponsors, together with translation agen-
cies in the geo-cultural groups concerned. Translation
standards for the PANSS followed internationally recog-
nized guidelines with the objective to achieve semantic
equivalence as outlined by Multi Health Systems (MHS
Translation Policy, available at http://www.mhs.com/
info.aspx?gr=mhs&prod=service&id=Translations). Se-
mantic equivalence is concerned with the transfer of
meaning across language.
Rater training
For the data used in this study, each PANSS rater was re-
quired to obtain rater certification through ProPhase LLC,
Rater Training Group, New York City, New York, and to
achieve interrater reliability with an intraclass correlation
coefficient = 0.80 with the “Expert consensus PANSS”
scores (or Gold Score rating), in addition to other speci-
fied item and scale level criteria. Gold Score is described
below. Only a Master’s level psychologist with one year ex-
perience working with schizophrenic patients and/or using
clinical rating instruments, or a PhD level Psychologist, or
Psychiatrist is eligible for PANSS rater certification. Rater
training on the PANSS required the following steps:
1. First, a comprehensive, interactive, didactic tutorial
was administered prior to the investigator meeting
for the specified clinical trial. The tutorial was
available at the Investigator’s Meeting, online, or on
DVD or cassette for others. The tutorial included a
comprehensive description of the PANSS and its
associated items, after which the rater was required
to view a video of a PANSS interview and rate each
item.
2. Second, the rater was provided with feedback
indicating the Gold Score rating of each item along
with a justification for that score. The Gold Score
rating was established by a group of four to five
Psychiatrists or PhD level Psychologists who have
administered the PANSS for ≥5 years. These
individuals rated each interview independently.Scores for each of the interviews were combined and
reviewed collectively in order to determine the Gold
Score rating.
3. Once the rater completed the above steps with the
qualifying scoring criteria, the rater was provisionally
certified to complete the PANSS evaluations.
Data
Data was obtained from ProPhase LLC Training Group
(New York, NY) and are data from raters who scored
PANSS training videos. The individuals depicted in the
videos are actors who provided consent. The study data
included PANSS scores from raters from the six geo-
cultural groups who underwent training and rated one
of 13 PANSS training videos. The symptoms presented
in the 13 videos spanned the spectrum of psychopath-
ology from absent to severe. Gold Scores for the 13 vid-
eos ranged from scores of 3 (Mild) to 6 (Severe) for Item
P1 Delusions, 2 (Minimal) to 5 (Moderate Severe) for P2
Conceptual Disorganization, and 1 (Absent) to 5 (Mod-
erate Severe) for the remaining Positive Symptom
subscale items. For the Negative Symptom subscale
items, scores ranged from 1 (Absent) to 5 (Moderate Se-
vere) for Items N1 Blunted Affect, N4 (Passive Apathetic
Social Withdrawal) and N6 Lack of Spontaneity and
Flow of Conversation, with ranges of 1 (Absent) to 4
(Moderate) for Item N2 Emotional Withdrawal and N3
Poor Rapport, and 1 (Absent) to 6 (Severe) for Difficulty
in Abstract Thinking. Scores on the 13 videos for the
General Psychopathology also ranged from 1 (Absent) to
4 (Moderate) and 5 (Moderate Severe) for most items,
with G9 Unusual Thought Content and G12 (Lack of
Judgment and Insight) ranging from scores of 3 (Mild)
to 6 (Severe). Data collection was conducted via a core
data collection form that included completion of all 30
items of the PANSS. The form also contained informa-
tion on one demographic variable of the raters which in-
cludes country of residency. The study recruitment took
place from 2007 to 2011.
Data was obtained for 1,179 raters. Table 1 consists of
sample characteristics and the distribution of countries
per geo-cultural group. Data for African raters were not
included in the analysis (i.e., 0.85% of total sample, n = 10;
N = 1,179) due to inadequate sample size needed for com-
parison. One can note that the percentages of data that
was removed for raters (from Africa (0.85%)) and for
missing PANSS items (0.0%) are all reasonably small.
These percentages point to the strong unlikelihood that
analyses of these data would not be compromised by
excluding these raters. It is not surprising to observe
relatively no missing responses for the PANSS as scores
on the instrument are incremental for training and
raters are required to score each item for rater training
and certification prior to the initiation of the study.





Northern Europe Belgium, Czech Republic, Estonia,
Aland (Finland), Germany, Lithuania,
Netherlands, Poland, Slovakia, United
Kingdom (UK), Hungary
126
Southern Europe Bulgaria, Croatia, Israel, Romania,
Serbia, Spain
162
Eastern Asia Korea, Malaysia, Singapore, Taiwan,
Japan
202
India Republic of India 185
Russia & Ukraine Russia, Ukraine 197
United States of
America
United States of America (US) 297
Africa South Africa 10
TOTAL 1,179
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tutional Review Board, Olympia, WA for secondary
analysis of existing data. Research involving human sub-
jects (including human material or human data) that is
reported in the manuscript was performed with the ap-
proval of an ethics committee (Western Institutional
Review Board (WIRB) registered with OHRP/FDA; re-
gistration number is IRB00000533, parent organization
number is IORG0000432.) in compliance with the Helsinki
Declaration.
Rasch analysis sample considerations
There are no established guidelines on the sample size
required for Rasch and DIF analyses. The minimum
number of respondents will depend on the type of
method used, the distribution of the item response in
the groups, and whether there are equal numbers in
each group. Previous suggestions for minimum sample
size for DIF analyses have usually been in the range of
100–200 per group [37,38] to ensure adequate perform-
ance (>80% power). For the present study, an item
shows DIF if there is not an equal probability of scoring
consistently on a particular PANSS item [39] (p. 264).
Selection of Geo-Cultural Groups
For this study, we assembled our data according to cul-
ture, with special attention to the presence and impact
of clinical trials, and to the geographic residence of the
raters. The resultant groups were defined prior to con-
sidering the amount of available data for each geo-
cultural group.. An attempt was made to include raters
who were likely to share more culturally within each
group. The geo-cultural groups aim to gather the raters
of a town, region, country, or continent on the basis
of the realities and challenges of their society. Usinggeography in part to inform our cultural demarcations
are not unproblematic or without limitations. Culture is
necessarily social and is not strictly rooted in geography
or lineage. However, the categories we elected for this
study take into account geography as this was the criter-
ion by which data were organized during rater training.
A few of our groups may appear unconventional at
first glance. We separated India from other parts of Asia
[38]. Table 1 presents the composition of the geo-
cultural groupings. The groups are discursive and artifi-
cial constructs intended solely for the purpose of this
study. No study of culture can involve all places and
facets of life simultaneously and thus will reflect only
generalities and approximations. For this reason, we
were forced to overlook the multiple cultural subjectiv-
ities and hybridity [40], acculturation and appropriation
[41], and fluidity that exist within and between the
groups we constructed. The authors chose to keep the
United States of America (US) as its own category since
the scale is a cultural product of the US and was initially
validated in this region.
As with any statistical analysis, if the categories were
assembled differently (i.e., including or excluding certain
groups, following a different organizing rationale) the
analyses may have yielded slightly different results. How-
ever, the authors felt that there were enough similarities
within the groupings: symptom expression and percep-
tion [42-44], clinical interview conduct [45], educational
pedagogy and experience [46,47], intellectual approach
[48], ideas about individuality versus group identity [49],
etc. to warrant our arrangement of data. An attempt also
was made to group countries with related histories, edu-
cational and training programs and ethnicities under the
assumption that the within-grouping differences are
likely to be less than the between-grouping differences.
Prevalence of English language fluency and exposure
was not considered in our categorization. While local
language training materials were made available in all
cases (i.e., transcripts of patient videos) some training
events included additional resources (i.e., translated di-
dactic slides, on-site translators). The range of English-
language comprehension varied greatly among raters as
well between and within many of the categories. The
variance caused by language itself or as a complex hy-
brid with cultural understanding and clinician experi-
ence with a measure or in clinical trials deserves more
attention [50]. Therefore, it is recommended that a sep-
arate analysis of the effects of language on inter-rater re-
liability be conducted.
Statistical methods
The Rasch measurement model assumes that the prob-
ability of a rater scoring an item is a function of the dif-
ference between the subject’s level of psychopathology
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the item. Analyses conducted included assessment of the
response format, overall model fit, individual item fit, dif-
ferential item functioning (DIF), and dimensionality.
Inter-rater reliability: The internal consistency of the
PANSS was tested through Cronbach α reliability coeffi-
cients whereas inter-rater reliability [51] was tested
based on intra class correlation coefficient (ICC). The
inter-rater reliability of the PANSS across all regions was
assessed. We classified ICC above 0.75 as excellent
agreement and below 0.4 as poor agreement [52].
Unidimensionality: DIF analyses assume that the un-
derlying distribution of θ (the latent variable, i.e., psy-
chopathology) is unidimensional [53], with all items
measuring a single concept; for this reason, the PANSS
subscales (Positive symptoms, Negative symptoms, and
General Psychopathology) were used, as opposed to a
total score. Dimensionality was examined by first con-
ducting principal components analysis (PCA) assess uni-
dimensionality as follows: (1) a PCA was conducted on
the seven Positive Symptom items, (2) the eigenvalues
for the first and second component produced by the
PCA were compared, (3) if the first eigenvalue is about
three times larger than the second one, dimensionality
was assumed. Similar eigenvalue comparison was conduc-
ted for the seven items of the Negative Symptoms subscale
and the 16 items of the General Psychopathology subscale
[54] for methods of assessing unidimensionality using
PCA). Suitability of the data for factor analysis was tested
by Bartlett's Test of Sphericity [55] which should be sig-
nificant, and the Kaiser-Meyer-Olkin (KMO) measure of
sampling adequacy, which should be >0.6 [56].
Rasch Analysis: For each PANSS item a separate
model was estimated using the response to that item as
the dependent variable. The overall subscale score for
the Positive symptoms, Negative symptoms, and General
Psychopathology scale, and each cultural grouping, was
the independent variables.
Two sets of Rasch analyses were conducted for each of
the 30 items from the PANSS scale.
1. Rasch analyses by geo-cultural grouping
To assess the measurement invariance of item calibra-
tions across countries in the present study, the Rasch
rating scale model was used [57]. The primary approach
to addressing measurement invariance involves the study
of group similarities and differences in patterns of re-
sponses to the items of the rating scale. Such analysis is
concerned with the relative severity of individual test
items for groups with dissimilar cultural or backgrounds.
It seeks to identify items for which equally qualified
raters from different cultural groups have different prob-
abilities of endorsing a score of a particular item on the
PANSS. To be used in different cultures, items mustfunction the same way regardless of cultural differences.
The Rasch model proposes that the responses to a set of
items can be explained by a rater’s ability to assess
symptoms and by the characteristics of the items. The
Rasch rating scale model is based on the assumption
that all PANSS subscale items have a shared structure
for the response choices. The model provides estimates
of the item locations that define the order of the items
along the overall level of psychopathology.
Rasch analysis makes a calibration of items based on
likelihood of endorsement (symptom severity). Inspec-
tion of item location is presented as average item cali-
brations (Δ Difficulty), goodness of fit (weighted mean
square) and standard error (SE). The Rasch analysis was
performed using jMetrik [58], where Δ Difficulty indi-
cates that the lower the number (i.e., negative Δ), the
less difficulty the rater has with that item. Taking into
account the set order of the item calibrations based on
ranking the Δ from smallest to largest, the adequacy of
each item can be further evaluated by examining the
pattern of easy and difficult items to rate based on cul-
ture (see Tables 2, 3 and 4b). When there is a good fit to
the model (i.e., weighted mean square (WMS)), re-
sponses from individuals should correspond well with
those predicted by the model. If the fit of most of the
items is satisfactory, then the performance of the instru-
ment is accurate. WMS fit statistics show the size of the
randomness, i.e., the amount of distortion of the meas-
urement system. Values less than 1.0 indicate observa-
tions are too predictable (redundancy, data overfit the
model). Values greater than 1.0 indicate unpredictability
(unmodeled noise, data underfit the model). Therefore a
mean square of 1.5 indicates that there is 50% more ran-
domness (i.e., noise) in the data than modeled. High
mean-squares (WMS >2.0) were evaluated before low
ones, because the average mean-square is usually forced
to be near 1.0. Since, mean-square fit statistics ave-
rage about 1.0, if an item was accepted with large
mean-squares (low discrimination, WMS >2.0), then
counter-balancing items with low mean-squares (high
discrimination, WMS < 0.50) were also accepted.
2. DIF analyses by geo-cultural grouping
Based on the results of Rasch analyses different ap-
proaches can be taken to account for weaknesses in the
scoring properties of the PANSS post-hoc. The Mantel-
Haenszel statistic is commonly used in studies of DIF,
because it makes meaningful comparisons of item per-
formance for different geographical groups, by compar-
ing raters of similar cultural backgrounds, instead of
comparing overall group performance on an item. In a
typical differential item functioning (DIF) analysis, a sig-
nificance test is conducted for each item. As the scale
consists of multiple items, such multiple testing may
Table 2 Reliability estimates of raters across six regions
Geo-cultural group Positive symptoms Negative symptoms General psychopathology Total PANSS score
Northern Europe
ICC (95% Confidence Interval) 0.987 (0.948, 0.996) 0.928 (0.831, 0.985) 0.926 (0.929, 0.984) 0.973 (0.958, 0.985)
Southern Europe
ICC (95% Confidence Interval) 0.991 (0.979, 0.998) 0.967 (0.921, 0.993) 0.982 (0.968, 0.993) 0.987 (0.980, 0.993)
Russia & Ukraine
ICC (95% Confidence Interval) 0.987 (0.969, 0.997) 0.975 (0.939, 0.995) 0.978 (0.960, 0.991) 0.983 (0.975, 0.990)
India
ICC (95% Confidence Interval) 0.986 (0.966, 0.997) 0.955 (0.895, 0.991) 0.981 (0.965, 0.993) 0.984 (0.975, 0.991)
Eastern Asia
ICC (95% Confidence Interval) 0.987 (0.969, 0.997) 0.953 (0.888, 0.990) 0.980 (0.963, 0.992) 0.981 (0.970, 0.989)
United States of America
ICC (95% Confidence Interval) 0.992 (0.980, 0.998) 0.965 (0.916, 0.993) 0.988 (0.978, 0.995) 0.990 (0.983, 0.994)
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once. Type I error rate can be affected by several factors,
including multiple testing. For DIF of the 30 item
PANSS the expectation is that 2 item response strings
have a probability of p ≤.05 according with the Rasch
model. α is the Type I error for a single test (incorrectly
rejecting a true null hypothesis). So, when the data fit
the model, the probability of a correct finding for one
item is (1-α), and for n items, (1-α)n. Consequently the
Type I error for n independent items is 1-(1-&alpha)n.
Thus, the level for each single test is α/n. So that for a
finding of p ≤ .05 to be found for 30 items, then at least
one item would need to be reported with p ≤ .0017 on a
single item test for the hypothesis that "the entire set of
items fits the Rasch model" to be rejected.
As the PANSS was developed in the US and the rater
training was conducted by a training facility in the US,
the authors chose to compare each geo-cultural group
to the US. Additionally, raters in similar geo-cultural
groups were compared (e.g., Northern European raters
vs. Southern European raters, Eastern Asian raters (will
here forth be referred to as Asia or Asian) vs. Indian
raters, Northern European raters vs. Russia & Ukraine
raters). The Mantel-Haenszel procedure is performed in
jMetrik and produces effect size computation and Edu-
cational Testing Services (ETS) DIF classifications as
follows:
A. = Negligible DIF
B. = Slight to Moderate DIF
C. = Moderate to Large DIF
Operational items categorized as C are carefully
reviewed to determine whether there is a plausible rea-
son why any aspect of that item may be unfairly related
to group membership, and may or may not be retained
on the test.Additionally, each category A, B or C is scored as ei-
ther – or + where,
- : Favors reference group (indicating the item is easier
to score for this group, than the comparison group)
+ : Favors focal group (indicating the item is easier to
score for this group, than the comparison group)
Results
Reliability
Reliability was assessed for each of the six geo-cultural
groups and results are as follows: Cronbach alpha (α) and
Intra Class Coefficients (ICC) for all groups were excellent
and Average Measures ICCs were significant at p < 0.001
for all groups (Northern Europe = Cronbach α = 0.977,
ICC = 0.973 (95% CI = 0.958, 0.985); Southern Europe =
Cronbach α = 0.989, ICC = 0.987 (95% CI = 0.980, 0.993);
India = Cronbach α = 0.987, ICC = 0.984 (95% CI = 0.975,
0.991); Asia = Cronbach α = 0.984, ICC = 0.981 (95%
CI = 0.970, 0.989); Russia & Ukraine = Cronbach α =
0.987, ICC = 0.983 (95% CI = 0.975, 0.990); United States
of America = Cronbach α = 0.991, ICC = 0.990 (95%
CI = 0.983, 0.994) (see Table 2).
Reliability for subscale measures also show excellent
reliability across all three subscales for each of the six
geo-cultural groups.
Assessment of unidimensionality
Principal Components Analysis (PCA) without rotation
revealed one component with an eigenvalue greater than
one for the Positive Symptoms subscale, one component
with an eigenvalue greater than one for the Negative
Symptoms subscale and four components with an eigen-
value greater than one for the General Psychopathology
subscale. Bartlett's Test of Sphericity was significant
(p < .001) for all three subscales and the Kaiser-Meyer-
Olkin (KMO) measure of sampling adequacy produced
values of 0.790, 0.877, and 0.821 for the Positive,
Table 3 Comparison between different geo-cultural groups of PANSS item Rasch rating scale item difficulty (Δ) and goodness of fit (weighted mean square
WMS values: positive symptoms, negative symptoms, general psychopathology
PANSS items Northern Europe Southern Europe India Eastern Asia Russia & Ukraine USA
Positive Symptoms Difficulty (Δ) WMS SE Difficulty (Δ) WMS SE Difficulty (Δ) WMS SE Difficulty (Δ) WMS SE Difficulty (Δ) WMS SE Difficulty (Δ) WMS SE
P1. −0.68 3.05 0.07 −0.79 2.86 0.05 −0.60 2.22 0.05 −0.52 1.49 0.04 −0.44 2.84 0.05 −0.38 1.34 0.06
P2. −0.26 2.26 0.06 −0.30 1.60 0.05 −0.13 2.18 0.05 −0.28 0.78 0.05 −0.22 1.67 0.06 −0.14 1.65 0.04
P3. −0.80 2.17 0.07 - 0.81 2.10 0.05 −0.79 0.94 0.10 −0.63 0.81 0.04 −0.63 0.81 0.04 −0.72 1.43 0.04
P4. 0.30 2.15 0.07 0.60 1.55 0.04 0.54 1.96 0.06 0.69 1.18 0.06 0.69 1.18 0.06 0.53 1.62 0.04
P5. −0.27 2.41 0.06 0.51 2.00 0.04 0.13 2.34 0.05 0.50 2.40 0.05 −0.54 2.03 0.05 −0.08 1.89 0.04
P6. −0.58 2.62 0.07 −0.69 1.89 0.06 −0.64 2.06 0.05 −0.69 1.48 0.05 −0.66 1.84 0.06 −0.93 1.90 −0.93
P7. 0.11 1.89 0.06 0.21 1.44 0.05 −0.09 1.84 0.05 0.03 0.75 0.04 0.23 1.39 0.06 0.12 1.59 0.12
Negative Symptoms Difficulty (Δ) WMS SE Difficulty (Δ) WMS SE Difficulty (Δ) WMS SE Difficulty (Δ) WMS SE Difficulty (Δ) WMS SE Difficulty (Δ) WMS SE
N1. −0.23 2.88 0.06 0.30 2.81 0.06 0.10 0.60 0.07 0.28 1.93 0.06 0.22 2.01 0.05 −0.23 2.88 0.06
N2. −0.25 1.61 0.06 −0.30 1.60 0.06 −0.38 1.47 0.05 −0.36 1.11 0.04 −0.22 1.57 0.05 −0.24 1.61 0.06
N3. 0.01 2.09 0.06 0.09 2.00 0.05 −0.26 1.00 0.05 0.08 0.90 0.05 0.10 2.11 0.05 0.01 2.09 0.06
N4. −0.18 1.68 0.06 −0.20 1.58 0.05 −0.19 1.30 0.05 −0.16 1.01 0.04 −0.13 1.67 0.06 −0.18 1.68 0.06
N5. −0.55 2.03 0.07 0.20 2.01 0.06 −0.56 1.34 0.05 0.15 0.74 0.06 0.16 2.02 0.06 −0.55 2.03 0.07
N6. −0.28 1.84 0.06 −0.10 1.80 0.05 −0.52 1.16 0.05 −0.19 0.82 0.04 −0.55 1.79 0.06 −0.28 1.84 0.06
N7. 0.21 1.46 0.06 0.43 1.41 0.06 0.69 1.22 0.08 0.29 0.84 0.05 0.60 1.31 0.07 0.21 1.46 0.06
General Psychopathology Difficulty (Δ) WMS SE Difficulty (Δ) WMS SE Difficulty (Δ) WMS SE Difficulty (Δ) WMS SE Difficulty (Δ) WMS SE Difficulty (Δ) WMS SE
G1. 0.22 1.99 0.06 0.41 1.18 0.07 0.63 1.51 0.06 0.55 0.80 0.06 0.40 1.10 0.06 0.80 1.78 0.05
G2. 0.10 1.58 0.10 0.15 1.05 0.09 0.01 1.86 0.05 −0.25 1.25 0.07 0.15 1.04 0.09 −0.01 1.02 0.05
G3. 0.72 2.23 0.08 1.00 2.01 0.07 1.38 1.82 0.09 0.81 1.38 0.07 1.41 1.05 0.05 0.93 2.36 0.06
G4. 0.29 1.71 0.07 0.39 1.00 0.05 0.46 1.47 0.06 0.29 0.62 0.05 0.57 1.04 0.05 0.39 0.96 0.04
G5. 0.69 1.40 0.08 0.23 1.14 0.07 0.86 1.21 0.07 1.12 1.25 0.08 1.11 1.24 0.07 0.84 1.44 0.05
G6. −0.06 2.66 0.06 0.90 1.06 0.06 0.37 2.59 0.05 0.66 1.67 0.06 0.97 1.32 0.06 0.34 0.76 0.05
G7. 0.40 1.55 0.07 0.41 1.50 0.06 0.04 1.26 0.05 0.01 0.89 0.04 0.47 1.35 0.05 0.27 0.64 0.04
G8. 0.23 1.63 0.06 0.79 0.74 0.09 0.10 1.64 0.05 0.16 0.71 0.05 0.77 0.76 0.05 0.13 1.09 0.04
G9. −0.34 2.77 0.06 −0.55 1.09 0.10 −0.08 2.00 0.05 −0.46 0.88 0.07 −0.34 1.23 0.09 −0.16 1.55 0.04
G10 0.41 0.71 0.08 0.06 0.77 0.07 0.22 1.27 0.05 0.20 1.32 0.05 0.21 1.22 0.05 0.69 1.42 0.05
G11. 0.27 1.39 0.07 0.01 0.82 0.08 0.17 1.46 0.05 0.03 0.77 0.04 0.22 1.02 0.07 0.31 1.10 0.04

















Table 3 Comparison between different geo-cultural groups of PANSS item Rasch rating scale item difficulty (Δ) and goodness of fit (weighted mean square
WMS values: positive symptoms, negative symptoms, general psychopathology (Continued)
G13. 0.12 1.87 0.06 0.24 1.80 0.05 0.04 1.61 0.05 −0.17 0.85 0.04 0.26 0.88 0.05 0.20 0.87 0.04
G14. 0.98 3.36 0.09 0.90 2.98 0.06 0.58 2.43 0.06 0.40 0.97 0.05 0.90 2.07 0.06 0.84 1.62 0.05
G15. 0.31 1.66 0.07 0.06 0.75 0.08 0.01 1.66 0.05 0.15 0.66 0.05 0.63 1.60 0.07 0.22 0.95 0.04
G16. −0.19 2.16 0.06 0.55 1.23 0.06 −0.29 2.03 0.05 −0.27 1.20 0.09 0.60 1.45 0.07 −0.55 2.10 0.04

















Table 4 Differential item functioning positive and negative symptoms: reference group = USA vs. focal group = Northern European, Southern Europe and
Russia & Ukraine
Northern Europe Southern Europe Russia & Ukraine USA
Item Chi-sq p-value E.S. (95% C.I.) Class Northern
Europe Mean
Chi-sq p-value E.S. (95% C.I.) Class Southern Europe Mean Chi-sq p-value E.S. (95% C.I.) Class Russo Europe USA Mean
P1 0.79 0.38 −0.02 (−0.21;0.17) A 4.60 (1.06) 27.73 < 0.001 −0.56
(−0.76;-0.35)
B- 3.66 (0.75)* 6.06 0.01 −0.31
(−0.50;-0.12)
BB- 3.86 (0.84) 4.29 (1.05)
P2 4.16 0.04 0.22
(−0.04;0.48)
A 3.97 (0.99) 26.9 < 0.001 0.83
(0.56;1.10)
C+ 4.05 (1.34)* 6.58 0.01 0.34
(0.12;0.55)
BB+ 3.56 (0.77) 3.42 (1.34)
P3 3.93 0.05 0.12
(−0.03;0.27)
A 4.79 (0.68) 4.48 0.03 0.20
(0.03;0.38)
A 4.24 (0.82) 8.68 < 0.001 0.24
(0.09;0.38)
AA 4.40 (0.84)* 4.33 (0.96)
P4 0.84 0.36 −0.07 (−0.26;0.12) A 3.11 (1.13) 2.55 0.11 −0.18
(−0.35;-0.01)
A 2.07 (1.25) 0.42 0.52 −0.04
(−0.21;0.12)
AA 2.40 (1.24) 2.70 (1.80)
P5 0.4 0.53 0.12
(−0.06;0.31)
A 3.98 (1.43) 40.17 < 0.001 −0.63
(−0.83;-0.42)
C- 2.10 (1.49)* 2.2 0.14 −0.04
(−0.23;0.15)
AA 2.87 (1.40) 3.34 (1.33)
P6 15.42 < 0.001 −0.33
(−0.51;-0.15)
B- 4.46 (0.88)* 12.95 < 0.001 −0.39
(−0.59;-0.20)
B- 1.09 (0.81)* 27.12 < 0.001 −0.59
(−0.80;-0.39)
BB- 3.88 (1.20)* 4.64 (1.02)
P7 0.3 0.59 −0.04 (−0.25;0.18) A 3.39 (0.93) 56.93 < 0.001 0.72
(0.53;0.91)
C+ 3.32 (1.03)* 14.33 < 0.001 0.41
(0.22;0.60)
BB+ 3.21 (1.13)* 3.05 (1.26)
N1 34.81 <0.001 −0.56
(−0.76;-0.36)
BB- 3.91 (1.30)* 1.89 0.17 −0.09
(−0.24;0.05)
AA 4.46 (1.29) 0.4 0.53 −0.03
(−0.26;0.19)
AA 4.10 (1.09) 4.01 (1.67)
N2 0.6 0.44 0.07
(−0.05;0.20)
AA 3.94 (0.55) 0.46 0.5 0.03
(−0.07;0.12)
AA 4.02 (0.61) 0.48 0.49 −0.08
(−0.22;0.06)
AA 3.63 (0.76) 3.85 (0.79)
N3 1 0.32 0.10
(−0.08;0.27)
AA 3.56 (1.30) 30.61 < 0.001 0.44
(0.29;0.59)
BB+ 4.04 (1.23)* 7.54 0.01 0.20
(0.05;0.34)
AA 3.24 (0.85) 3.26 (1.51)
N4 0.01 0.93 0.01
(−0.16;0.17)
AA 3.84 (0.99) 37.25 < 0.001 −0.55
(−0.70;-0.39)
BB- 3.49 (0.84)* 2.27 0.13 0.02
(−0.15;0.19)
AA 3.52 (0.87) 3.74 (1.23)
N5 0.03 0.86 −0.03 (−0.23;0.18) AA 4.41 (1.14) 15.71 < 0.001 −0.36
(−0.55;-0.18)
BB- 4.04 (1.07)* 7.78 0.01 −0.24
(−0.44;-0.04)
AA 3.94 (0.94) 4.16 (1.32)
N6 0.93 0.33 0.06
(−0.12;0.24)
AA 3.99 (1.39) 20.58 < 0.001 0.36
(0.20;0.51)
BB+ 4.39 (1.30)* 9.07 < 0.001 0.02
(−0.17;0.21)
AA 3.54 (1.08)* 3.52 (1.73)
N7 10.44 <0.001 0.35
(0.15;0.56)
BB+ 3.25 (0.86)* 2.44 0.12 0.18 (−0.00;0.37) AA 3.21 (0.99) 0.33 0.57 0.11
(−0.06;0.29)
AA 2.89 (0.77) 2.17 (1.15)
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http://www.biomedcentral.com/2050-7283/1/5Negative and General Psychopathology subscales, re-
spectively. Using the criteria to assess unidimensionality
of the eigenvalue for the first component being three
times larger than the second component, the Positive
and Negative Symptoms subscales indicate unidimen-
sionality while the General Psychopathology subscale
shows an eigenvalue on the second component of only
1.230 times larger than the first component. Although
the General Psychopathology subscale was not unidi-
mensional, basic steps for validating items were met, i.e.,
intraclass correlations were all ≥ 0.90, and the items of
the General Psychopathology subscale was evenly dis-
tributed and linear.
Rasch analysis
Most items showed high mean squares (WMS > 2.0 or
low discrimination). Poor fit does not mean that the Rasch
measures (parameter estimates) aren't additive (appropri-
ate). The Rasch model forces its estimates to be additive.
So a WMS > 2.0 suggests a deviation from unidimension-
ality in the data, not in the measures. Therefore, values
greater than 2.0 (see Table 3) indicate unpredictability
(unmodeled noise, model underfit). Items with high WMS
were examined first (to assess which items may have been
influenced by outliers), and temporarily removed from the
analysis, before investigating the items with low WMS,
until WMS values were closer to 1.0.
Positive symptoms
Average item calibrations and goodness of fit values for
each PANSS Positive subscale item for the 6 geo-
cultural groups are presented in Table 3. Lower item
calibration reflects items easy to endorse, in which raters
often showed less difficulty scoring; higher item calibra-
tion reflects items more difficultly scoring. Items varied
in severity from −0.93 [item P6. Suspiciousness/persecu-
tion (USA) to 0.69 item P4. Excitement (Asia)]. Item P3
(Hallucinatory Behavior) was the easiest item to score
for all geo-cultural groups ranging from Russia &
Ukraine (Δ = −0.82) to Asia (Δ = −0.63), followed by
item P6 (Suspiciousness/Persecution), which ranged
from United States (Δ = −0.93) to Northern Europe
((Δ = −0.58). All geo-cultural groups found item P4
(Excitement) the most difficult to score across all
items. With difficulty levels ranging from Δ = 0.69
(Asia) to Δ = 0.30 (Northern Europe). P5 (Grandiosity)
was the most difficult for Southern Europe (Δ = 0.51)
and Asia (Δ = 0.50). Overall, the goodness-of-fit of the
PANSS Positive items was satisfactory across all geo-
cultural groups.
Negative symptoms
Average item calibrations and goodness of fit values for
each PANSS Negative subscale item for the 6 geo-cultural groups are presented in Table 3. Lower item
calibration reflects items easy to endorse, in which raters
often showed less difficulty scoring; higher item calibra-
tion reflects items more difficultly scoring. Items varied
in severity from −0.56 [item N5. Difficulty in Abstract
Thinking (India)] to 0.69 [item N7. Stereotyped Think-
ing (India)]. Item N5 (Difficulty in Abstract Thinking)
was the easiest in Northern Europe, USA (Δ = −0.55
respectively), and India (Δ = −0.56). For the remaining
items, the easiest item to rate was N2 (Emotional
Withdrawal) for Southern Europe (Δ = −0.30) and Asia
(Δ = −0.36). The easiest Negative symptom item to
score for Russia & Ukraine is N6 (Lack of Spontaneity
and Flow of Conversation), Δ = −0.55. The most difficult
item to score for all groups is N7 (Stereotyped Thinking)
with India showing the most difficulty Δ = 0.69, and
Northern Europe and the United States of America show-
ing the least difficulty Δ = 0.21, each. The second most
difficult item for raters to score was N1 (Blunted Affect)
for most groups including Southern Europe (Δ = 0.30),
Asia (Δ = 0.28), Russia & Ukraine (Δ = 0.22) and India
(Δ = 0.10). Russia & Ukraine also had difficulties scoring
N5 (Difficulty in Abstract Thinking) Δ = 0.16. Overall,
the goodness-of-fit of the PANSS Positive items was sat-
isfactory across all geo-cultural groups.
General psychopathology symptoms
Average item calibrations and goodness of fit values for
each PANSS General Psychopathology subscale item for
the 6 geo-cultural groups are presented in Table 3.
Lower item calibration reflects items easy to endorse, in
which raters often showed less difficulty scoring; higher
item calibration reflects items more difficultly scoring.
Items varied in severity from −0.75 [G12 Lack of Judg-
ment and Insight (India)] to 1.41 [item G3 Guilt Feelings
(Russia & Ukraine)]. All geo-cultural groups had item
G12 (Lack of Judgment and Insight) as the least difficult
item to score with Indian raters having the least diffi-
culty (Δ = −0.75), along with item G2 (Anxiety) with
Asian raters having the least difficulty (Δ = −0.25).
Northern European raters had the least difficulty with
item G6. Depression (Δ = −0.06). Other items which were
easier to score included G16 (Active Social Avoidance) for
United States raters (Δ = −0.55), Indian raters (Δ = −0.29),
Asian raters (Δ = −0.27). However, Southern European
raters, and Russian & Ukrainian raters had item G16
among the most difficult to score, with Δ = 0.55 and
Δ = 0.60, respectively.
The most difficult item for raters to score for all
groups is G4 (Tension) with difficulty levels ranging
from Δ = 1.38 (India) to Δ = 0.72, and item G3 (Guilt
Feelings) for Russia & Ukraine raters (Δ = 1.41). Also,
G10 (Disorientation) for Northern Europe (Δ = 0.41),
India (Δ = 0.22), Asia (Δ = 0.20), and the United States
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cultural groups also showed difficulties rating this item
(see Table 2). Also, raters from Asia had difficulties scor-
ing item G5 (Mannerisms and Posturing), Δ = 0.81).
Raters from Southern Europe, India, Asia, Russia &
Ukraine and the United States of America also had diffi-
culties scoring item G14 (Poor Impulse Control) with
item difficulty ranging from Δ = 0.90 (Southern Europe)
to Δ = 0.40 (Asia). Russia & Ukraine also had significant
difficulty with item G15 (Preoccupation). Overall, the
goodness-of-fit of the PANSS Positive items was satisfac-
tory across all geo-cultural groups.
Differential item functioning analysis
Positive symptoms
Northern Europe: Significant DIF was found for items
P6. Suspiciousness/Persecution (Chi Square = 15.42,
p < 0.001) for USA and Northern Europe. P6 Suspicious-
ness/Persecution shows Slight to Moderate DIF (Class B)
favoring the US (or reference group) (see Table 4).
Southern Europe: Significant DIF was found for items
P1. Delusions, P2. Conceptual Disorganization, P5. Gran-
diosity, P6. Suspiciousness/Persecution and P7. Hostility
for Southern European raters compared to USA raters. Of
the significant items, P1. Delusions, and P6. Suspicious-
ness/Persecution shows slight to moderate DIF (Class B)
favoring the United States (reference group), whilst P2.
Conceptual Disorganization, and P7. Hostility shows Mod-
erate to Large DIF (Class C) favoring Southern Europe.
Moderate to large DIF (Class C) is also seen for P5 Gran-
diosity favoring the US (see Table 4).Table 5 Differential item functioning positive and negative sy
and East & Maritime Asia
India
Item Chi-sq p-value E.S. (95% C.I.) Class India Chi
P1 2.4 0.12 −0.15 (−0.32;0.02) A 4.19 (0.99) 7.55
P2 0.01 0.94 0.06 (−0.17;0.29) A 3.46 (1.32) 1.72
P3 8.78 < 0.001 0.25 (0.10;0.40) A 4.53 (0.96)* 0.01
P4 0.39 0.53 −0.07 (−0.22;0.07) A 2.55 (1.18) 6.78
P5 2.62 0.11 −0.16 (−0.34;0.02) A 3.08 (1.70) 7.27
P6 19.93 < 0.001 −0.37 (−0.53;-0.21) B- 4.25 (0.78)* 5.77
P7 22.91 < 0.001 0.44 (0.26;0.61) B+ 3.39 (0.86)* 14.2
N1 7.86 0.01 −0.20 (−0.34;-0.06) AA 4.05 (1.50) 0.09
N2 0.02 0.9 0.01 (−0.09;0.12) AA 3.85 (0.77) 0.59
N3 15.16 < 0.001 0.31 (0.17;0.45) BB+ 3.66 (1.41)* 3.45
N4 8.98 < 0.001 −0.23 (−0.37;-0.09) AA 3.55 (1.01)* 4.91
N5 2 0.16 −0.15 (−0.33;0.03) AA 4.14 (1.23) 1.57
N6 13.42 < 0.001 0.29 (0.13;0.44) AA 4.06 (1.62)* 0
N7 0.02 0.88 −0.03 (−0.22;0.17) AA 2.89 (1.21) 2.81
* Bonferroni Corrected p <0 .0017; E.S.: Effect Size; Chi-sq: Chi Square.Russia & Ukraine: Significant DIF was found for items
P3. Hallucinatory Behavior, P6. Suspiciousness/Persecution,
and P7. Hostility for Russia & Ukraine raters compared to
USA raters. Of the significant items, P6. Suspiciousness/
Persecution showed Slight to Moderate DIF (Class B) fa-
voring the USA raters, whilst P7. Hostility showed slight to
moderate DIF favoring Russia & Ukraine. Negligible DIF
(Class A) was observed for P3. Hallucinatory Behavior (see
Table 4).
India: Significant DIF was found for items P3. Hallu-
cinatory Behavior, P6. Suspiciousness/Persecution, and
P7. Hostility for Indian raters compared to USA raters.
Of the significant items, P6. Suspiciousness/Persecution
shows slight to moderate DIF (Class B) favoring the
United States (reference group), whilst P7. Hostility
shows slight to moderate DIF (Class B) favoring India.
Negligible DIF (Class A) was observed for P3. Hallucin-
atory Behavior (see Table 5).
Asia: Significant DIF was found for P7. Hostility for
Asian raters compared to USA raters. P7. Hostility was
showed Slight to Moderate DIF (Class B) favoring Asian
raters (see Table 5).
Negative symptoms
Northern Europe: Significant DIF was found for items
N1. Blunted Affect and N7. Stereotyped Thinking for
Northern European raters compared to US raters. Of the
significant items N1. Blunted Affect showed slight to
moderate DIF (Class B) favoring USA and N7. Stereo-
typed Thinking showed slight to moderate DIF (Class B)
favoring Northern Europe (see Table 4).mptoms: reference group = USA vs. focal group = India
Eastern Asia
-sq p-value E.S. (95% C.I.) Class Eastern Asia USA Mean
0.01 −0.32 (−0.52;-0.13) BB- 3.89 (1.01) 4.29 (1.05)
0.19 0.29 (0.06;0.52) AA 3.52 (1.81) 3.42 (1.34)
0.94 −0.03 (−0.23;0.17) AA 4.06 (1.18) 4.33 (0.96)
0.01 0.19 ( 0.03;0.36) AA 2.43 (1.12) 2.70 (1.80)
0.01 −0.28 (−0.49;-0.06) AA 2.47 (1.65) 3.34 (1.33)
0.02 −0.29 (−0.46;-0.11) AA 4.16 (0.87) 4.64 (1.02)
1 < 0.001 0.43 (0.23;0.64) BB+ 3.07 (1.06)* 3.05 (1.26)
0.76 0.09 (−0.06;0.24) AA 3.85 (1.66) 4.01 (1.67)
0.44 −0.10 (−0.21;0.01) AA 3.65 (0.69) 3.85 (0.79)
0.06 0.16 (0.01;0.30) AA 3.00 (1.29) 3.26 (1.51)
0.03 −0.16 (−0.29;-0.04) AA 3.34 (0.77) 3.74 (1.23)
0.21 −0.12 (−0.31;0.06) AA 3.83 (1.41) 4.16 (1.32)
0.98 −0.01 (−0.16;0.14) AA 3.24 (1.33) 3.52 (1.73)
0.09 0.15 (−0.02;0.33) AA 2.88 (1.83) 2.17 (1.15)
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Poor Rapport, N4. Passive Apathetic Social Withdrawal,
N5. Difficulty in Abstract Thinking, and N6. Lack of
Spontaneity/Flow of Conversation for Southern European
raters compared to US raters. N4. Passive Apathetic Social
Withdrawal and N5. Difficulty in Abstract Thinking
showed slight to moderate DIF (Class B) favoring US, and
N3. Poor Rapport and N6. Lack of Spontaneity/Flow of
Conversation showed slight to moderate DIF (Class B) fa-
voring Southern Europe (see Table 4).
Russia & Ukraine: Significant DIF was found for N6.
Lack of Spontaneity and Flow of Conversation; Negli-
gible DIF (Class A) was observed for scores obtained for
raters from Russia & Ukraine compared to US raters
(see Table 4).
India: Significant DIF was found for items N3. Poor
Rapport, N4. Passive Apathetic Social Withdrawal, and
N6. Lack of Spontaneity and Flow of Conversation for
Indian raters compared to USA raters. Of the significant
items, only N3. Poor Rapport showed slight to moderate
DIF (Class B) Indian Raters. Negligible DIF (Class A)
was observed for N4. Passive Apathetic Social With-
drawal, and N6. Lack of Spontaneity and Flow of Con-
versation (see Table 5).
Asia: No significant DIF was found for Asian raters
compared to US raters (see Table 5).
General psychopathology
Northern Europe: Significant slight to moderate DIF
(Class B) DIF was observed for G2. Anxiety, G3. Guilt
Feelings, G6. Depression, G7. Motor Retardation, G9.
Unusual Thought Content, and G16. Active Social
Avoidance. G2. Anxiety, G3. Guilt Feelings, G6. Depres-
sion, G7. Motor Retardation, and G16. Active Social
Avoidance favored the USA raters; G3. Guilt Feelings
and G9. Unusual Thought Content favored the Northern
Europe raters. Items G1. Somatic Concern and G10. Dis-
orientation showed moderate to severe DIF (Class C)
both favoring Northern Europe raters (see Table 6).
Southern Europe: Significant slight to moderate DIF
(Class B) DIF was observed for G7. Motor Retardation,
G12. Lack of Judgment and Insight, and G16. Active So-
cial Avoidance. and G16. Active Social Avoidance fa-
vored the USA raters; G7. Motor Retardation, and G12.
Lack of Judgment favored the Southern Europe raters.
Items G2. Anxiety, G3. Guilt Feelings, G6. Depression,
G10. Disorientation, G11. Poor Attention, G13. Disturb-
ance of Volition, and G14. Poor Impulse Control,
showed moderate to severe DIF (Class C) with G2. Anx-
iety, G3. Guilt Feelings, and G6. Depression favoring the
USA raters, and G10. Disorientation, G11. Poor Atten-
tion, G13. Disturbance of Volition, and G14. Poor Im-
pulse Control favoring the Southern Europe raters (see
Table 6).Russia & Ukraine: Significant slight to moderate DIF
(Class B) DIF was observed for most items, G1. Somatic
Concerns, G2. Anxiety, G3. Guilt Feelings, G6. Depres-
sion, G8. Uncooperative, G10. Disorientation, G13. Dis-
turbance of Volition, and G14. Poor Impulse Control.
G1. Somatic Concerns, G10. Disorientation, G13. Dis-
turbance of Volition, and G14. Poor Impulse Control fa-
vored Russia & Ukraine, while G2. Anxiety, G3. Guilt
Feelings, G6. Depression and G8. Uncooperative favored
the US raters (see Table 6).
India: Table 6 shows, significant slight to moderate
DIF (Class B) DIF was observed for G3. Guilt Feelings,
and G14. Poor Impulse Control; G3. Guilt Feelings fa-
vored the US raters and G14. Poor Impulse Control fa-
vored the Indian raters. Significant moderate to severe
DIF (Class C) were found for G2. Anxiety, G6. Depres-
sion, G10. Orientation, and G12. Lack of Judgment and
Insight, with G2. Anxiety and G6. Depression favoring
US raters and G10. Orientation, G12. Lack of Judgment
and Insight favoring Indian raters.
Asia: Table 6 shows, significant slight to moderate DIF
(Class B) for G1. Somatic Concerns, G2. Anxiety, G5.
Mannerisms and Posturing; G9. Unusual Thought Con-
tent, G10. Disorientation, G11. Poor Attention, G12.
Lack of Judgment/Insight, G13. Disturbance of Volition,
and G14. Poor Impulse Control. G1, G9, G10, G11, G12,
G13, and G14 favored Asian raters, while G5 and G16
favored US raters. Moderate to severe DIF (Class C) was
observed for G6 Depression favoring US raters.
Discussion
This article is the first to publish a cross-cultural com-
parison of the psychometric performance, mean scale
scores, and item and scale-summary for the PANSS
using qualified raters who rated one of 13 standardized
training videos of a patient in the United States. Our
aim was to perform a cross-cultural validity assessment
by checking DIF due to cultural factor in a sample of
qualified raters from 6 different geo-cultural groups. The
results showed that there were significant differences in
response to a number of items on the PANSS.
The Intra Class Correlations (ICCs) for the PANSS total
score for the United States group was marginally higher
than the ICC for the other geo-cultural groups. Although
all reliability estimates were excellent (i.e., >= 0.80), all
groups had the lowest ICCs for the Negative symptom
subscale compared to the Positive symptom and General
Psychopathology subscales suggesting increased variability
among scores for the Negative symptom subscale.
Rasch analysis and differential item functioning (DIF)
Although the PANSS was originally designed with three
subscales (Positive, Negative, and General Psychopath-
ology), studies examining the internal structure of the
Table 6 Differential item functioning positive and negative symptoms: reference group = USA vs. focal group = Northern Europe, Southern Europe, Russia &
Ukraine, India, Eastern Asia
Northern Europe Southern Europe Russia & Ukraine India Eastern Asia
Item Chi-sq p-value E.S. (95% C.I.) Class Chi-sq p-value E.S.
(95% C.I.)
Class Chi-sq p-value E.S. (95% C.I.) Class Chi-sq p-value E.S.
(95% C.I.)
Class Chi-sq p-value E.S.
(95% C.I.)
Class
G1 17.54* <0.001 0.73
(0.40;1.06)
CC+ 1.74 0.19 0.19
(−0.09;0.48)
AA 12.94* < 0.001 0.46
(0.23;0.69)
BB+ 1.07 0.3 0.15
(−0.09;0.39)
AA 12.67* <0.001 0.50
(0.24;0.76)
BB+
G2 21.95* <0.001 −0.55
(−0.79;-0.30)
BB- 57.91* <0.001 −0.77
(−0.98;-0.56)
CC- 12.2* < 0.001 −0.35
(−0.55;-0.16)
BB- 36.56* <0.001 −0.66
(−0.88;-0.45)
CC- 15.96* <0.001 −0.47
(−0.69;-0.24)
BB-
G3 3.85* <0.001 0.38
(0.04;0.72)
BB+ 19.01* <0.001 −0.62
(−0.91;-0.34)
CC- 8.58* < 0.001 −0.39
(−0.64;-0.14)
BB- 13.56* <0.001 −0.49
(−0.75;-0.24)
BB- 0.65 0.42 −0.08
(−0.33;0.17)
AA
G4 0.13 0.72 0.08
(−0.15;0.31)
AA 4.52 0.03 −0.21
(−0.38;-0.03)
AA 3.84 0.05 −0.15
(−0.34;0.03)
AA 5.85 0.02 −0.26
(−0.42;-0.10)
AA 0.96 0.33 −0.08
(−0.25;0.09)
AA
G5 0.29 0.59 −0.10
(−0.37;0.17)
AA 7.32 0.01 −0.35
(−0.57;-0.14)
BB- 4.11 0.04 0.07
(−0.13;0.27)
AA 2.01 0.16 −0.15
(−0.36;0.06)
AA 21.1* <0.001 −0.43
(−0.63;-0.23)
BB-
G6 6.72 0.01 −0.42
(−0.71;-0.14)
BB- 96.09* <0.001 −1.56
(−1.88;-1.24)
CC- 12.62* < 0.001 −0.44
(−0.68;-0.20)
BB- 43.1* < 0.001 −0.96
(−1.24;-0.67)
CC- 101.6* <0.001 −1.42
(−1.70;-1.13)
CC-
G7 7.99* <0.001 −0.35
(−0.56;-0.14)
BB- 14.83* <0.001 0.33
(0.14;0.52)
BB+ 0.05 0.82 −0.08
(−0.30;0.14)
AA 9.06* < 0.001 0.28
(0.10;0.46)
AA 4.75 0.03 0.21
(0.01;0.40)
AA
G8 0.38 0.54 −0.06
(−0.27;0.14)
AA 0.24 0.63 0.01
(−0.19;0.20)
AA 19.24* < 0.001 −0.40
(−0.61;-0.19)
BB- 1.22 0.27 0.15
(−0.03;0.33)
AA 1.95 0.16 −0.12
(−0.30;0.06)
AA
G9 12.25* <0.001 0.47
(0.19;0.74)
BB+ 0.45 0.5 −0.09
(−0.29;0.11)
AA 4.92 0.03 −0.30
(−0.49;-0.10)
AA 0.42 0.52 −0.07
(−0.29;0.15)
AA 24.13* <0.001 0.55
(0.33;0.76)
BB+
G10 12.43* <0.001 0.62
(0.32;0.93)
CC+ 51.21* <0.001 0.81
(0.59;1.03)
CC+ 24.08* < 0.001 0.54
(0.35;0.72)
BB+ 35.63* < 0.001 0.63
(0.42;0.84)
CC+ 21.37* <0.001 0.47
(0.25;0.69)
BB+
G11 0.03 0.86 0.00
(−0.20;0.20)
AA 38.47* <0.001 0.64
(0.43;0.86)
CC+ 0.37 0.54 −0.02
(−0.19;0.15)
AA 1.68 0.19 0.13
(−0.05;0.31)
AA 12.14* <0.001 0.30
(0.12;0.48)
BB+
G12 3.91 0.05 0.24
(0.01;0.48)
AA 16.84* <0.001 0.44
(0.21;0.66)
BB+ 8.07* < 0.001 0.28
(0.08;0.49)
AA 44.49* < 0.001 0.76
(0.54;0.98)
CC+ 17.92* <0.001 0.40
(0.19;0.62)
BB+
G13 0.03 0.86 −0.12
(−0.32;0.08)
AA 46.14* <0.001 0.61
(0.43;0.79)
CC+ 19.82* < 0.001 0.32
(0.14;0.50)
BB+ 4.2 0.04 0.16
(−0.02;0.35)
AA 16.89* <0.001 0.34
(0.16;0.52)
BB+
G14 1.73 0.19 −0.22
(−0.49;0.05)
AA 27.31* <0.001 0.60
(0.39;0.81)
CC+ 20.86* < 0.001 0.48
(0.29;0.67)
BB+ 8.34* < 0.001 0.31
(0.10;0.53)
BB+ 20.34* <0.001 0.40
(0.21;0.58)
BB+
G15 6.35 0.01 −0.29
(−0.54;-0.04)
AA 8.39* <0.001 0.27
(0.08;0.46)
AA 2.91 0.09 0.19
(0.01;0.37)
AA 8.29* < 0.001 0.28
(0.08;0.48)
AA 0.04 0.84 −0.01
(−0.18;0.17)
AA
G16 7.97* <0.001 −0.40
(−0.69;-0.11)
BB- 9.45* <0.001 −0.31
(−0.51;-0.10)
BB- 8.93* < 0.001 −0.21
(−0.39;-0.03)
AA 6.01 0.01 −0.27
(−0.50;-0.04)
AA 31.17* <0.001 −0.56
(−0.77;-0.35)
BB-

















Khan et al. BMC Psychology 2013, 1:5 Page 14 of 18
http://www.biomedcentral.com/2050-7283/1/5scale [59-61] have all identified the same two underlying
factors, Positive and Negative. Other factors have varied
and included Disorganized, Excitement, Hostility, Dys-
phoric, Catatonic and many more [15,62,63]. Given that
Rasch analysis depend on how symptom severity is defined,
the appropriateness of modeling of items via their subscale
scores, rather than a total PANSS score was confirmed by
conducting PCA on each subscale to assess unidimension-
ality. Although the PCA of the General Psychopathology
subscale did not assume unidimensionality, it is common
practice in clinical trials to examine the Positive and Nega-
tive subscales independently from the rest of the scale since
these symptoms are considered a key component of the
disease [15] and are symptom clusters which are primarily
targeted in drug development.
While variation was present in the order and location of
some PANSS items for geo-cultural groups, the overall
pattern of item calibration was generally congruent.
Within each of the six groups, the Rasch model also con-
firmed the hierarchical structure of the PANSS items, as
evidenced by the pattern of average item calibrations and
goodness-of-fit indices. In each region, most item calibra-
tions were well spaced along the continuum of psycho-
pathology, suggesting that for the groups included in this
study, the PANSS is able to measure a wide range of func-
tion in schizophrenia. Items which were found to be easy
to score by all geo-cultural groups included P3 (Hallucin-
atory Behavior), P6 (Suspiciousness/Persecutory Behavior),
G12 (Lack of Judgment and Insight), and G2 (Anxiety).
Additionally, results indicated that Northern European
raters were more likely to endorse higher scores on all
Positive symptom items except N7 (Stereotyped Thinking)
compared to other regions. It should be noted, the first
three items generally load on the Positive symptom factor
domain in factor analytic studies [60,61]. The Positive fac-
tor is comprised of the most active and first rank symp-
toms that define schizophrenia and it is primarily with
these symptoms that a diagnosis is made clinically of
schizophrenia. Therefore, raters may find it easier to score
items which are first rank or core features of schizophre-
nia as these symptoms are also present in the diagnostic
criteria.
In addition to the items listed above, raters from
Northern Europe, the US and India found item N5 (Dif-
ficulty in Abstract Thinking) to be easier items to score.
It should be noted that this item is intended to be based
on objective responses by the patient, and not rater’s
subjective interpretation. It can be suggested that items
with clear scoring instructions related to objective re-
sponse (e.g., if the subject answers four out of four prov-
erbs correct, a score of one should be given) are easier
to score across most geo-cultural groups. Other items
which were observed to be easier to score include N2.
Emotional Withdrawal (Southern Europe, and Asia),G12. Lack of Spontaneity and Flow of Conversation
(Russia & Ukraine), G6. Depression (Northern Europe),
and G16. Active Social Avoidance (United States of
America, India, and Asia). With the exception of G6
(Depression), the latter items generally load on a Nega-
tive factor domain [60,61]. The Negative factor reflects
the difficulties in social relatedness often exhibited in
many schizophrenic patients and are considered second
rank symptoms. Again, more prevalent symptoms of
schizophrenia and are first and second rank symptoms
are easier to score across most countries. It should be
noted that, upon evaluation of mean scores, Southern
European raters scored higher on most Negative symp-
tom subscale items (N1 Blunted Affect, N2 Emotional
Withdrawal, N5 Difficulty in Abstract Thinking, and N6
Lack of Spontaneity and Flow of Conversation), whereas
the lowest scores for Negative symptom items were from
raters from Asia for N1 Blunted Affect, N3 Poor Rap-
port, N5 Difficulty in Abstract Thinking, and N7 Stereo-
typed Thinking compared to other geo-cultural groups.
All geo-cultural groups had significant DIF for P4 (Ex-
citement), N7 (Stereotyped Thinking), and G10 (Disorien-
tation). Santor and colleagues [28] have demonstrated that
many items (N7 and G10) have problematic features and
some fundamental issues with relation to the level of psy-
chopathology measured by the overall PANSS. Our own
item response analysis [30], has also demonstrated signifi-
cant DIF with item G10 (Disorientation) with regards to
its contribution to the assessment of psychopathology as
measured by the PANSS. Additionally, previous psycho-
metric investigations have indicated that item G10 (Dis-
orientation) either does not discriminate well in terms of
assessing overall severity or does not reflect dimensional
individual differences between patients within schizophre-
nia [15,62]. Similarly, all groups showed significant slight
to moderate DIF with the US raters for item G10 (Dis-
orientation). This item measures the lack of awareness of
the subject’s relationship to their surroundings and as-
sesses specific questions relating to the subject’s know-
ledge of his/her doctor, address, and political figures.
Therefore, this item may also lack a relationship to psy-
chopathology, rather than cultural/geographical differ-
ences in scoring patterns.
The main source of rater differences among items were
observed for the General Psychopathology subscale with
five items showing different rating patterns across geo-
cultural groups (i.e., G3 Guilt Feelings (Russia & Ukraine),
G5 Mannerisms and Posturing (Asia), G16 Active Social
Avoidance (Southern Europe and Russia & Ukraine), G14
Poor Impulse Control (all regions except Northern Europe),
G15 Preoccupation (Russia & Ukraine)). Although support
for the PANSS General Psychopathology subscale has been
found in other studies [13], the current findings suggest the
rating for items on the General Psychopathology subscale
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http://www.biomedcentral.com/2050-7283/1/5differ for European and Japanese raters and it should not be
assumed that the same, standard rating tools were applied
indiscriminately across these groups.
There are several possible explanations for discre-
pancies among raters both between and within the geo-
cultural groups examined [63]. One of the possible
reasons may be interpretation variance. Interpretation
variance implies that once raters agree on the common
criteria, when there are differences, it is more frequently
because of decision-making differences in the scoring of
the item. Thus, when training a cohort of raters, it may
be necessary to focus part of the training on cultural dif-
ferences and expectations on different thresholds of
symptoms. There were significant moderate to large DIF
(i.e., ETS Class scores of C) for most items scored by
Southern European raters compared to US raters. Differ-
ent social views due to cultural influence might lead to
different rating of social and emotional behaviors. Des-
pite the fact that the Positive and Negative subscales
met the other Rasch model requirements, the presence
of DIF by region means that culture might contribute to
the scores on these items. Therefore, when clinical trial
investigators pool PANSS data from different countries,
items showing DIF should be removed or split. An itera-
tive “top-down purification” splitting approach for items
showing uniform DIF has been applied elsewhere [26].
Yet another possible source of differing reliability may
be cultural biases found in common-place standardized
training methods and materials. Using standardized pa-
tients (patients who are trained to portray specific sets
of symptoms), it has been demonstrated that video-
recorded or tape-recorded interviews increases inter-
rater reliability even among raters with limited exposure
to the PANSS (e.g., [64]) and affective measures [65]. As
such, a culturally diverse group of raters was asked to
evaluate cultural idioms, symptom expressions, and so-
cial dynamics during the interview which may have been
unfamiliar. It can be argued that higher inter-rater reli-
ability may therefore be associated with a higher degree
of acculturation amongst raters as much as it is an indi-
cation of rater comprehension and agreement.
Limitations
There are some limitations to this study. First, this ana-
lysis focuses on a small cohort of raters from only six
geo-cultural groups who rated US training videos. This
sample is not representative of all PANSS raters and pa-
tients within the geo-cultural groups (except the US);
hence findings may not be generalizable across different
regions (e.g., South America, Latin America, and areas
of Africa). Also, a similar analytic technique using data
obtained in clinical trials (utilizing patients from the spe-
cific geo-cultural region) is currently underway by this
research team. Secondly, this study addresses reliabilitycross-sectionally, and not longitudinally. Additional stud-
ies would be needed to address differences in PANSS
scores across time. Unfortunately in this analysis, we were
unable to access data to adjust for possible confounding
variables such as level of rater qualifications, amount of
experience in the field of schizophrenia, or gender, and
recognize that these may influence the differences in mean
scale scores. This is, however, a common limitation of
cross-cultural comparisons of any subjective or objective
data where local socio-demographic conditions vary in
their definition and measurement. Since this is the first
cross-cultural study of the PANSS and not taking into ac-
count the presence of confounding sample characteristics
other than geographically defined culture, these findings
should to be taken in a preliminary and cautionary man-
ner. More specifically, how rater training is translated in
the geo-cultural regions could not be examined using the
currently available data, and should be addressed in future
cross-cultural studies. Additionally, culture may influence
responses to the PANSS for many reasons. For example,
some Hispanics have been noted to express emotional and
mental health as physical health symptoms [66], which
may be different from non-Hispanics. Also, Klienman and
Good [67] reported individuals with depression may be
less likely to report sadness or anxiety, but more likely to
report sleep problems or appetite changes. The authors
recognize that wide variations exist in educational level,
occupational status, and cultural identity within commu-
nities of raters, therefore as much as geo-cultural
matching was attempted, the authors recognize the limita-
tions of the selection of countries per group. Finally, al-
though Rasch analysis allows for the detection of DIF
within the current sample size, future studies should at-
tempt to replicate these results using greater and more
balanced sample sizes across regions.
Conclusions
This is the first Rasch analysis of the PANSS in a global
setting across cultures. One strength of the Rasch ana-
lysis is that problematic items are clearly flagged and
specific modifications can be identified to improve rater
training and data surveillance of the PANSS. The results
showed support for the two subscales (i.e., Positive and
Negative symptoms) with recommendations to further
assess administration and scoring of specific items; how-
ever, the General Psychopathology subscale was shown
to be a multidimensional subscale warranting further re-
view. Attention to cultural bias in training curricula and
delivery may help to reduce these elements as con-
founders in future inquiries. The results of the current
study further emphasize the need for rigorous individu-
alized training and rater surveillance of scores on the
PANSS across different groups, to decrease sources of
unreliability. Clearly further research is warranted to
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